Crossmark

Response to the Letter to the Editor Regarding “Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials”

Crossref DOI link: https://doi.org/10.1007/s10875-017-0438-y

Published Online: 2017-09-05

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suez, Daniel

Stein, Mark

Gupta, Sudhir

Hussain, Iftikhar

Melamed, Isaac

Paris, Kenneth

Darter, Amy

Bourgeois, Christelle

Fritsch, Sandor

Leibl, Heinz

McCoy, Barbara

Gelmont, David

Yel, Leman
Funding

Funding for this research was provided by:

Shire
License Information

License valid from 2017-09-05